Cancer

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies. Read More

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer. Read More

Using technology he helped develop, Vanderbilt University scientist Bryan Venters, Ph.D., has shed new light on the “dark matter” of the genome and has begun to explore a possible new approach to treating cancer. Read More

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug. Read More

Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time. Read More

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read More

A motor protein that helps drive cell division may be a promising new target for cancer therapeutics. Read More

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor. Read More

Puck Ohi, Ph.D., assistant professor of Cell and Developmental Biology, has received the Leukemia & Lymphoma Society SCHOLAR award for his research on the role of enzymes that affect cell division, which has implications for treating cancer and blood disorders like leukemia and lymphoma. Read More

The future of cancer is becoming clearer. And it’s not looking so good for cancer. Read More

The gene Has2 participates in signaling that is important in developing fingers and toes, and may have relevance for cancer development. Read More

There’s a long list of Vanderbilt faculty and staff who made an impact on Terri and Steve Voland when Steve was treated at Vanderbilt-Ingram Cancer Center for a rare type of cancer in his neck and spine. Read More

A novel class of drugs that target “BET” proteins may have broad utility for treating genetically diverse brain tumors. Read More

Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute. Read More

Vanderbilt researchers report that they have found a factor involved in the persistence of embryonic cells implicated in childhood liver cancer. Read More

Cancer patients undergoing some forms of chemotherapy often lose some or all of their hair, as well as eyebrows and eyelashes. Read More

The protein TIP-1 appears to be a novel prognostic marker for glioblastoma and may be a good therapeutic target for disrupting tumor-driven blood vessel development. Read More

Nearly every week since 1988, cancer patients and families visiting Vanderbilt University Medical Center have been able to count on a comforting routine — at least one morning per week they are greeted by the same smiling volunteer who dispenses a dose of friendship along with coffee, snacks and advice about how to navigate the sprawling Medical Center campus. Read More

Vanderbilt and University of California investigators have discovered the “cell of origin” for pancreatic ductal adenocarcinoma, a finding that could lead to early detection methods and new treatments. Read More

Cancer death rates for most forms of cancer have continued to decline in the United States among men and women and all major racial and ethnic groups, according to the latest Annual Report to the Nation on the Status of Cancer. Read More